Treatment Response and Outcome with Two Different Prednisolone Regimens in Autoimmune Hepatitis
DIGESTIVE DISEASES AND SCIENCES, cilt.62, sa.10, ss.2900-2907, 2017 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 62 Sayı: 10
- Basım Tarihi: 2017
- Doi Numarası: 10.1007/s10620-017-4728-2
- Dergi Adı: DIGESTIVE DISEASES AND SCIENCES
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.2900-2907
- Hacettepe Üniversitesi Adresli: Evet
Özet
Beyond available guidelines, therapy of autoimmune hepatitis (AIH) shows wide variation among physicians. We compared two regimens for treatment naive AIH: one recommended protocol with an initial prednisolone dose of 30 mg/day and our own 40 mg/day prednisolone with a slow dose tapering protocol. We analyzed the safety, response rates, and outcomes for two groups of treated patients.